Sustained, Around-the-Clock Pain Relief:
The extended-release formulation of TRD Contin 100 is engineered to deliver a slow, controlled release of tramadol hydrochloride over an extended dosing period, ensuring that therapeutic plasma levels are maintained consistently. This eliminates the pain breakthroughs that can occur between doses with immediate-release formulations, providing your canine or feline companion with uninterrupted comfort throughout the day.

Dual-Action Analgesic for Comprehensive Pain Control:
TRD Contin 100 targets pain through both opioid receptor engagement and monoamine reuptake inhibition, making it effective across a broader spectrum of pain types than single-mechanism analgesics. This dual-action profile makes it particularly valuable for managing neuropathic pain, post-operative discomfort, and the complex chronic pain associated with degenerative joint disease or oncological conditions.

Reduced Dosing Frequency for Improved Compliance:
The controlled-release design of this tablet means fewer administrations are required compared to immediate-release tramadol, significantly reducing the stress of repeated oral medication for sensitive or treatment-averse pets. Improved dosing compliance translates directly into more consistent therapeutic outcomes and a better quality of life for your companion animal.

Suitable for Multimodal Pain Management Protocols:
TRD Contin 100 is well-established in veterinary practice as a safe component of multimodal analgesia, where it is used alongside non-steroidal anti-inflammatory drugs (NSAIDs) such as carprofen or meloxicam to achieve superior pain control. Combining tramadol with NSAIDs allows veterinarians to address both the inflammatory and neurological components of pain while potentially reducing the dose and associated risks of each individual drug.

Preferred by Veterinary Pain Specialists:
Tramadol's well-documented efficacy and favourable tolerability profile in dogs and cats have made it a preferred choice of veterinarians in the management of both acute and chronic pain scenarios. TRD Contin 100's controlled-release format specifically aligns with the needs of long-term pain management, offering a reliable, consistent analgesic option that supports your pet's daily mobility and overall wellbeing.

How to Use:

TRD Contin 100 Tablet must be administered strictly as prescribed by a licensed veterinarian. The tablet should be given orally and may be offered with or without food; however, administration with food or a treat is recommended to minimise the risk of gastrointestinal upset and to mask the tablet's bitter taste, which may otherwise cause reluctance in some pets. The tablet must never be crushed, broken, split, or chewed, as doing so will destroy the extended-release matrix and result in rapid, uncontrolled release of the full tramadol dose, which could be dangerous. Always administer the tablet whole, exactly as directed. Do not adjust the dose, increase the frequency of administration, or discontinue treatment abruptly without consulting your veterinarian, as sudden cessation in patients on long-term therapy may result in withdrawal symptoms. If a dose is missed, administer as soon as possible, but do not double the dose to compensate. This medication must only be used in the specific animal for which it has been prescribed.

Storage Advice:

Store unopened TRD Contin 100 Tablets in a cool, dry place below 25 degrees Celsius, away from direct sunlight and moisture. Do not freeze. As a Schedule H controlled substance, this medication must be stored securely in a locked cabinet or safe at all times, and the quantity of medication remaining should be regularly monitored to prevent diversion or accidental access. Keep this product strictly out of reach of children and other pets. Do not use after the best-before date printed on the blister pack or carton.

About the Brand:

Modi Mundi Pharma Pvt. Ltd. is a well-established Indian pharmaceutical manufacturer with a legacy of producing high-quality formulations across multiple therapeutic categories, including analgesics, controlled-release preparations, and critical care medicines. The company adheres to the stringent manufacturing standards set by India's Central Drugs Standard Control Organisation (CDSCO) and operates within a regulatory framework designed to ensure the safety, efficacy, and consistency of every product leaving its facilities. Modi Mundi Pharma's research and development approach centres on leveraging advanced drug delivery technologies, such as controlled-release matrix systems, to optimise the pharmacokinetic performance of established active compounds for maximum patient benefit. Their commitment to pharmaceutical precision, quality raw material sourcing, and consistent production standards aligns with Animeal's commitment to offering only trusted, clinically validated products to the pets and families we serve. Discover Modi Mundi Pharma today.

Disclaimer:

Please note that while TRD Contin 100 Tablet is formulated from tramadol hydrochloride 100 mg in an extended-release matrix and is appropriate for use in dogs and cats under veterinary direction, it is a Schedule H prescription-only opioid analgesic and must not be dispensed, administered, or obtained without a valid veterinary prescription. This product is intended solely for the specific animal to which it has been prescribed and must never be used in any other animal or human. Administration without professional guidance carries serious risks including respiratory depression, seizures, sedation, and opioid dependence. For pets with pre-existing hepatic or renal insufficiency, a history of seizures, or those currently receiving CNS depressants, antidepressants, or other opioid medications, consult your veterinarian before introducing this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.